These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28649056)

  • 21. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator.
    Asada T; Yoshihara N; Ochiai Y; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 541(1-2):246-252. PubMed ID: 29496456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of mucoadhesive matrix tablets of taro gum: optimization using response surface methodology.
    Arora G; Malik K; Singh I
    Polim Med; 2011; 41(2):23-34. PubMed ID: 21866794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mini-tablets as technological strategy for modified release of morphine sulfate.
    Silva RTCE; Bruschi ML
    Pharm Dev Technol; 2022 Sep; 27(7):766-772. PubMed ID: 36017971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.
    Adeleye OA; Femi-Oyewo MN; Odeniyi MA
    Polim Med; 2014; 44(4):209-20. PubMed ID: 25932902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preparation of hydrophilic matrix sustained release tablets of total lactones from Andrographis paniculata and study on its in vitro release mechanism].
    Xu FF; Shi W; Zhang H; Guo QM; Wang Zhen-Zhong ; Bi YA; Wang ZM; Xiao W
    Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(1):79-83. PubMed ID: 25993792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Prosopis africana Seed Gum as an Extended Release Polymer for Tablet Formulation.
    Nadaf S; Nnamani P; Jadhav N
    AAPS PharmSciTech; 2015 Jun; 16(3):716-29. PubMed ID: 25523143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics.
    Ravi PR; Kotreka UK; Saha RN
    AAPS PharmSciTech; 2008; 9(1):302-13. PubMed ID: 18446496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuro-fuzzy modeling of ibuprofen-sustained release from tablets based on different cellulose derivatives.
    Rebouh S; Lefnaoui S; Bouhedda M; Yahoum MM; Hanini S
    Drug Deliv Transl Res; 2019 Feb; 9(1):162-177. PubMed ID: 30341764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and evaluation of non-effervescent floating tablets of losartan potassium.
    Getyala A; Gangadharappa HV; Prasad MS; Reddy MP; Kumar TM
    Curr Drug Deliv; 2013 Oct; 10(5):620-9. PubMed ID: 23286884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of a cross-linked hydrogel of Karaya gum and Starch as a controlled drug delivery system.
    Sethi S; Kaith BS; Kaur M; Sharma N; Khullar S
    J Biomater Sci Polym Ed; 2019 Dec; 30(18):1687-1708. PubMed ID: 31443620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation development and in-vitro evaluation of gastroretentive drug delivery system of loxoprofen sodium: A natural excipients based approach.
    Zaman M; Akhtar F; Baseer A; Hasan SMF; Aman W; Khan A; Badshah M; Majeedullah -
    Pak J Pharm Sci; 2021 Jan; 34(1):57-63. PubMed ID: 34248003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained release isoniazid tablets. I--Formulation and in vitro evaluation.
    Bulut-Oner F; Capan Y; Kas S; Oner L; Hincal AA
    Farmaco; 1989; 44(7-8):739-52. PubMed ID: 2590371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical Product Lead Optimization for Better In vivo Bioequivalence Performance: A case study of Diclofenac Sodium Extended Release Matrix Tablets.
    Shahiwala A; Zarar A
    Curr Drug Deliv; 2018; 15(5):705-715. PubMed ID: 29165078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of Ketoprofen sustained release matrix tablet using
    Kaleemullah M; Jiyauddin K; Thiban E; Rasha S; Al-Dhalli S; Budiasih S; Gamal OE; Fadli A; Eddy Y
    Saudi Pharm J; 2017 Jul; 25(5):770-779. PubMed ID: 28725150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.